Упрощенная HTML-версия
111
100.
/91/-.&, . . %&'(%&)&*+1/$.+2 $%(%0$ C&):-76 68&-+1/$.+'+
4+==0D-7'+ D(C&)/9(-+,'+ 3/1/-+: (9%&8/=. 4+$. ... .(-4. '/4. -(0. /
. .
/91/-.&; --% 3&97Z. .9()+=+.(5++ /4/8. 038. '/4-C+&). +
F.$%8/'(). 38&C).
. - ., 2002. - 24 $.
53450. /8[(%/)+
4&.0'/-%(: '
.
101.
?/).&-&*&9(,
. .
)+-+1/$.(,,
5+%&'&8=&)&*+1/$.(,,
'+.8&C+&)&*+1/$.(, 6(8(.%/8+$%+.( + )/1/-+/ 3&8([/-+2 $)+D+$%&2
&C&)&1.+ 3&)&$%+ 8%( 0 01($%-+.&9 )+.9+4(5++ 3&$)/4$%9+2 (9(8++ -(
/8-&C7):$.&2 (%&'-&2 F)/.%8&$%(-5++: (9%&8/=. 4+$. ... .(-4. '/4. -(0.
/
. . ?/).&-&*&9(; /8'$.(, *&$. '/4. (.(4. - /8':, 2001. - 26 $.
53010. /8[(%/)+ 4&.0'/-%(: '
.
102.
/',.+-(, .
.
$$)/4&9(-+/ $&4/8[(-+, .():5+, 9 $)H-/
3(5+/-%&9, 3&49/8*(9Z+6$, 9&D4/2$%9+H '()76 4&D +&-+D+80HI/*&
+D)01/-+, / .
.
/',.+-(, . . &*&[-+.&9, . . +'&-&9 // /8'. '/4.
[08-. – 2003. – 20, _ 2. – . 136-138.
103.
C)&.&9(, .
. 5/-.( $&$%&,-+, &8*(-&9 3&)&$%+ 8%( 0 -($/)/-+,,
38&[+9(HI/*& 9 8(2&-(6, 3&49/8*Z+6$, 8(4+(5+&--&'0 D(*8,D-/-+H:
(9%&8/=. 4+$. ... .(-4. '/4. -(0. / .
.
C)&.&9(;
&$.. *&$. '/4.-
$%&'(%&). 0--%. - ., 2003. - 18 $.
54831. /8[(%/)+ 4&.0'/-%(:
'
.
104.
Nifedipine induces gingival epithelial hyperplasia in rats through
inhibition of apoptosis / Y. Shimizu, M. Kataoka, H. Seto et al. // J.
Periodontol. – 2002. – Vol. 73, _ 8. – P. 861-867.
105.
Zervakis, J. Taste effects of lingual application of cardiovascular
medications / J. Zervakis, B.G. Graham, S.S. Schiffman // Physiol. Behav. –
2000. – Vol. 68, _ 3. – P. 405-413.
106.
Comparative study of calcium-channel blockers on cell proliferation,
DNA and collagen syntheses, and EGF receptors of cultured gingival
fibroblasts derived from human nifedipine, nicardipine and nisoldipine